Search results for: patents

Haptics in the Automotive Sector – Encouraging Adoption and Maximising Returns Through Patents

There has been a widely-reported growth of new technology and interest in the automotive sector in recent years.  We now expect our vehicles to do more than ever before and this trend is forecast...

Chemical Patents: Increasing Value With Experimental Strategies | 03.08.20

Monday 3rd August 2020, 2:00pm (London UK – BST) 45mins What will the talk cover? GJE Expert IP Talks will be delving into all of the core areas of IP practice.  The focus will be on UK and Eur...

Petri Dish of the Day: Appetite Increases for Lab-Grown Meat Patents

This article was co-authored by Olly Beswestherick “Fifty years hence, we shall escape the absurdity of growing a whole chicken in order to eat the breast or wing by growing these parts separately u...

The President of the EPO Is Determined to Prevent Patents Issuing Directed to Plants Obtained by Essentially Biological Processes

In a notice published yesterday, the President of the EPO has decided to stay any examination or opposition proceedings at the EPO where the patent application or patent in question claims a plant or ...

Green Patents for Green Software

Computer technology moves fast. New software products can have a short shelf life before they become obsolete and are replaced by something else. This can produce some issues for the patent system, bu...

Innovation in the agri-tech space: How hard does the “essentially biological process” exclusion bite?

We examine why it is crucial for agri-tech companies to have awareness of the ''essentially biological process'' exclusion and when alternatives to patent protection should be considered....

Cultivating protection: The UK system for plant breeders’ rights

We highlight some of the key features of the current UK regime for plant variety protection, and underscore strategic considerations for managing PBRs as part of an international IP portfolio....

Key considerations when patenting antibody-drug conjugates in Europe

Antibody-drug conjugates (ADCs) are a biotherapeutic modality typically used for the treatment of cancer....

GJE announces alliance with Wächtershäuser & Hartz

GJE is pleased to announce that the firm has formed an alliance with the German patent and trade mark firm Wächtershäuser & Hartz (W&H)...

GJE recommended as leading patent attorneys by IP Stars 2025

GJE is delighted that we have been recommended as a leading firm of patent attorneys in the IP Stars 2025 rankings. Published by Managing IP, the annual IP Stars survey recommends the world’s leadin...